超声引导下肝癌热消融的应用及进展

doi:10.11904/j.issn.1002-3070.2022.04.018

摘要/Abstract

摘要： 肝癌是临床上常见的恶性肿瘤之一,在全球恶性肿瘤发病顺位居第六,并有升高趋势,严重危害人们的身体健康。目前肝癌的主要治疗方式有外科手术、局部热消融以及肝移植。近几年来,局部热消融在肝脏恶性肿瘤中受到越来越广泛的应用。本文就超声引导下热消融技术在肝癌中的应用及相关新技术进行综述。

关键词: 肝癌, 超声, 热消融

Abstract: Liver cancer is one of the common malignant tumors in the clinic.The incidence of liver cancer ranks sixth among all kinds of malignant tumors in the world and is increasing year by year,which has seriously endangered people's health.The current main treatment methods include surgery,local thermal ablation,and liver transplantation.In recent years,local thermal ablation has become more and more widely used in liver malignancies.This article reviews the application of ultrasound-guided thermal ablation in liver cancer and related new technologies.

Key words: Liver cancer, Ultrasound, Thermal ablation

中图分类号:

R735.7

李磊, 张磊, 程文. 超声引导下肝癌热消融的应用及进展[J]. 实用肿瘤学杂志, 2022, 36(4): 386-390.

LI Lei, ZHANG Lei, CHENG Wen. Application and progress of ultrasound-guided thermal ablation of liver cancer[J]. Journal of Practical Oncology, 2022, 36(4): 386-390.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.04.018

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I4/386

参考文献

1 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
2 李进军.多极射频消融仪治疗肝癌的研究进展[J].中国医疗器械信息,2021,27(14):20-21.
3 Nault JC,Sutter O,Nahon P,et al.Percutaneous treatment of hepatocellular carcinoma:state of the art and innovations[J].J Hepatol,2018,68(4):783-797.
4 Izzo F,Granata V,Grassi R,et al.Radiofrequency ablation and microwave ablation in liver tumors:an update[J].Oncologist,2019,24(10):990-1005.
5 Kawamura Y,Ikeda K,Shindoh J,et al.No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection[J].Hepatol Res,2019,49(2):164-176.
6 Huang Q,Li J,Zeng Q,et al.Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery[J].BMC Cancer,2020,20(1):763.
7 应希慧,张登科,陈丽,等.放射性粒子植入在原发性肝癌射频消融后应用人群的初步探讨[J].中华医学杂志,2020,(17):1310-1314.
8 Huang G,Lin M,Xie X,et al.Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinoma[J].Eur Radiol,2014,24(7):1565-1571.
9 Piskin FC,Balli HT,Aikimbaev K.Safety and efficacy analysis of microwave ablation in small hepatocellular carcinomas sized below 3 cm[J].Pol J Radiol,2020,85:202-208.
10 Chong C,Lee KF,Cheung S,et al.Prospective double-blinded randomized controlled trial of microwave versus radiofrequency ablation for hepatocellular carcinoma(mcRFA trial)[J].HPB(Oxford),2020,22(8):1121-1127.
11 Dong LN,Yu XL,Cheng ZG,et al.Comparison of parallel and crossed placement of antennas in microwave ablation of 3-5 cm hepatocellular carcinoma[J].Abdom Radiol(NY),2019,44(6):2293-2300.
12 凌云彪,张小丹,吴宇轩,等.超声引导下第二肝门旁肝细胞癌热消融疗效[J].中华肝脏外科手术学电子杂志,2020,9(5):479-483.
13 Orlacchio A,Bolacchi F,Chegai F,et al.Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm[J].Radiol Med,2014,119(5):298-308.
14 张丹,李曾,柏艳红,等.超声引导下激光与射频消融治疗小肝癌的临床疗效差异[J].肝脏,2019,24(6):666-669.
15 Chai W,Zhao Q,Kong D,et al.Percutaneous laser ablation of hepatic tumors located in the portacaval space:preliminary results[J].Lasers Surg Med,2019,51(10):866-873.
16 Ji Y,Zhu J,Zhu L,et al.High-intensity focused ultrasound ablation for unresectable primary and metastatic liver cancer:real-world research in a chinese tertiary center with 275 cases[J].Front Oncol,2020,10:519164.
17 Sun M,Shang P,Bai J,et al.High-intensity focused ultrasound ablation combined with transcatheter arterial chemoembolization improves long-term efficacy and prognosis of primary liver cancer[J].J Clin Lab Anal,2021,35(2):23633.
18 Tsang SH,Ma KW,She WH,et al.High-intensity focused ultrasound ablation of liver tumors in difficult locations[J].Int J Hyperthermia,2021,38(2):56-64.
19 Mulier S,Ni Y,Jamart J,et al.Local recurrence after hepatic radiofrequency coagulation:multivariate meta-analysis and review of contributing factors[J].Ann Surg,2005,242(2):158-171.
20 陈良,刘艳芳,孙勤学,等.射频消融联合肝动脉化疗栓塞治疗直径3cm以上原发性肝癌的疗效和影响因素分析[J].现代实用医学,2019,31(5):590-592.
21 Smolock AR,Cristescu MM,Hinshaw A,et al.Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3~5 cm hepatocellular carcinoma when compared with transarterial chemoembolization alone[J].Abdom Radiol(NY),2018,43(9):2497-2504.
22 Gravante G,Sconocchia G,Ong SL,et al.Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies[J].Liver Int,2009,29(1):18-24.
23 Wang X,Liu G,Chen S,et al.Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma:a propensity score matching analysis[J].Int J Hyperthermia,2021,38(1):1519-1528.
24 Leuchte K,Staib E,Thelen M,et al.Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma[J].Cancer Immunol Immunother,2021,70(4):893-907.
25 Cheng AL,Kang YK,Chen Z,et al.Efficacy and safety of sorafenib in patients in the asia-pacific region with advanced hepatocellular carcinoma:a phase III randomised,double-blind,placebo-controlled trial[J].Lancet Oncol,2009,10(1):25-34.
26 付志豪,陈海明,王亚东,等.射频消融联合索拉菲尼治疗中晚期肝细胞癌的疗效及预后影响因素[J].重庆医学,2020,49(5):714-717.
27 Peng Z,Chen S,Wei M,et al.Advanced recurrent hepatocellular carcinoma:treatment with sorafenib alone or in combination with transarterial chemoembolization and radiofrequency ablation[J].Radiology,2018,287(2):705-714.
28 Xu E,Long Y,Li K,et al.Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors[J].Int J Hyperthermia,2019,35(1):159-167.
29 Yosuke K,Kazushi N,Manabu M,et al.Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with GD-EOB-DTPA to detect small hepatocellular carcinoma[J].AJR,2012,198(1):106-114.
30 Li XQ,Wang X,Zhao DW,et al.Application of GD-EOB-DTPA-enhanced magnetic resonance imaging(MRI)in hepatocellular carcinoma[J].World J Surg Oncol,2020,18(1):219.
31 Calandri M,Mauri G,Yevich S,et al.Fusion imaging and virtual navigation to guide percutaneous thermal ablation of hepatocellular carcinoma:A review of the literature[J].Cardiovasc Intervent Radiol,2019,42(5):639-647.
32 Wu L,Chen J,Li K,et al.Potential application of ultrasound-guided thermal ablation in rare liver tumors[J].Hepatobiliary Pancreat Dis Int,2018,17(06):531-537.
33 Zhu Y,Xu JX,Cheng J,et al.A novel injectable thermo-sensitive binary hydrogels system for facilitating endoscopic submucosal dissection procedure[J].United European Gastroenterol J,2019,7(6):782-789.
34 Zhang L,Xia G,Liu Y,et al.Effect of a poloxamer 407-based thermosensitive gel on minimization of thermal injury to diaphragm during microwave ablation of the liver[J].World J Gastroenterol,2017,23(12):2141-2148.
35 Hu J,Chen S,Wang X,et al.Image-guided percutaneous microwave ablation versus cryoablation for hepatocellular carcinoma in high-risk locations:intermediate-term results[J].Cancer Manag Res,2019,11:9801-9811.
36 Lindner LH,Hossann M.Factors affecting drug release from liposomes[J].Curr Opin Drug Discov Devel,2010,13(1):111-123.
37 Jin Ys,Liang XL,An YK,et al.Microwave-triggered smart drug release from liposomes coencapsulating doxorubicin and salt for local combined hyperthermia and chemotherapy of cancer[J].Bioconjugate Chemistry,2016,27(12):2931-2942.
38 Zhang N,Wu Y,Xu W,et al.Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy[J].Drug Deliv,2022,29(1):506-518.

[1]	那军, 安晓霞, 李恂, 张薇薇, 穆慧娟, 礼彦侠, 潘国伟, 刘莉. 辽宁省三城市居民2000—2002年肝癌10年生存率分析[J]. 实用肿瘤学杂志, 2022, 36(4): 293-298.
[2]	唐如冰, 王琪, 游雪梅. 肝癌共病抑郁分子机制的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 239-244.
[3]	庞春华, 李繁荣, 唐如冰, 覃蕾, 赵新华, 唐娟, 游雪梅. 术前疲乏状态与中晚期肝细胞癌患者术后生活质量的关联性:一项前瞻性队列研究[J]. 实用肿瘤学杂志, 2022, 36(2): 127-132.
[4]	陈赫, 王秋程, 程文. 自动乳腺超声诊断系统在乳腺癌方面的应用进展[J]. 实用肿瘤学杂志, 2022, 36(2): 193-196.
[5]	周天虹, 顾秀瑛, 姚芳, 宋述铭. 乌鲁木齐市2014—2018年度乳腺癌筛查结果分析[J]. 实用肿瘤学杂志, 2021, 35(5): 391-395.
[6]	陈雪健, 王伟, 周健, 李宁, 张浩鹏, 徐力善. 瑞戈非尼联合哌立福辛诱导人肝癌HepG2细胞凋亡的分子机制研究[J]. 实用肿瘤学杂志, 2021, 35(5): 408-413.
[7]	郭兰伟, 张韶凯, 刘曙正, 郑黎阳, 陈琼, 曹小琴, 孙喜斌, 张建功. 河南省城市地区乳腺癌筛查依从性及其影响因素分析[J]. 实用肿瘤学杂志, 2021, 35(4): 307-313.
[8]	黎敏, 冉立, 常建英. 影像学技术在图像引导宫颈癌近距离放射治疗中的应用[J]. 实用肿瘤学杂志, 2021, 35(3): 263-267.
[9]	朱云芳, 陈杨, 朱林芳, 石青萍, 成会荣, 任思颖, 文洪梅. 2016年云南省肿瘤登记地区肝癌发病和死亡情况及2011—2016年变化趋势[J]. 实用肿瘤学杂志, 2021, 35(2): 97-102.
[10]	胡启辉, 杜毅超, 贺凯, 付文广, 夏先明. 内质网应激在肝癌中的作用[J]. 实用肿瘤学杂志, 2021, 35(2): 160-164.
[11]	白明宇, 陈丽莉. 2015—2019年营口市城市居民肝癌死因分析[J]. 实用肿瘤学杂志, 2020, 34(6): 500-503.
[12]	刘红, 鲁海玲, 蔡莉. 影像学预测乳腺癌患者预后及新辅助化疗反应的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 535-539.
[13]	石琳娜, 隋红. 原发性肝癌免疫检查点抑制剂治疗的进展与挑战[J]. 实用肿瘤学杂志, 2020, 34(6): 560-564.
[14]	袁瑶, 周显礼. 乳腺癌超声特征与腋窝淋巴结转移相关性的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 576-580.
[15]	赵仁成, 林子棠, 余卫军, 雷林, 刘峥, 徐英, 郭艳芳, 彭绩. 2017—2019年深圳市宝安区40~74岁常住居民五癌风险流行状况分析[J]. 实用肿瘤学杂志, 2020, 34(4): 315-320.